Cargando…
Statins as early therapy to mitigate COVID-19 (SARS-CoV-2)-associated ARDS and cytokine storm syndrome – time is of the essence
Autores principales: | Teoh, Narci, Farrell, Geoff |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Whioce Publishing Pte. Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326274/ https://www.ncbi.nlm.nih.gov/pubmed/32617428 |
Ejemplares similares
-
On the role of bacterial metalloproteases in COVID-19 associated cytokine storm
por: Földvári-Nagy, László, et al.
Publicado: (2021) -
Transcription Factor Nrf2 as a Potential Therapeutic Target for Prevention of Cytokine Storm in COVID-19 Patients
por: Zinovkin, R. A., et al.
Publicado: (2020) -
The novel immunomodulatory biologic LMWF5A for pharmacological attenuation of the “cytokine storm” in COVID-19 patients: a hypothesis
por: Thomas, Gregory, et al.
Publicado: (2020) -
SARS-COV-2 as an artificial creation: scientific arguments and counterarguments
por: Yee, Shermaine, et al.
Publicado: (2021) -
COVID-19 Tragic Pandemic: Concerns over Unintentional “Directed Accelerated Evolution” of Novel Coronavirus (SARS-CoV-2) and Introducing a Modified Treatment Method for ARDS
por: A., Ghadimi-Moghadam, et al.
Publicado: (2020)